Table 2. Concordance of FISH and RT–PCR positivity according to EWSR1-rearranged neoplasm subtype.
Positive FISH; Positive RT–PCR |
Positive FISH; Negative RT–PCR |
Positive FISH; Failed RT–PCR |
Positive FISH; RT–PCR ND |
Negative FISH; Positive RT–PCR |
Negative FISH; Negative RT–PCR |
Negative FISH; Failed RT–PCR |
Negative FISH; RT–PCR ND |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histology | Samples tested | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % |
Ewing sarcoma | 109 | 45 | 41.3 | 15 | 13.8 | 12 | 11.0 | 17 | 15.6 | 4 | 3.7 | 4 | 3.7 | 5 | 4.6 | 5 | 4.6 |
DRSCT | 22 | 9 | 40.9 | 0 | 0.0 | 3 | 13.6 | 7 | 31.8 | 2 | 9.1 | 1 | 4.5 | 0 | 0.0 | 0 | 0.0 |
Myxoid LPS (FISH and RT–PCR comparison not possible due to lack of commercial EWSR1-DDIT3 primers) | 24 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
EMC | 41 | 14 | 34.1 | 7 | 17.1 | 1 | 2.4 | 2 | 4.9 | 0 | 0.0 | 11 | 26.8 | 1 | 2.4 | 4 | 9.8 |
AFH | 20 | 9 | 45.0 | 2 | 10.0 | 0 | 0.0 | 1 | 5.0 | 4 | 20.0 | 3 | 15.0 | 0 | 0.0 | 0 | 0.0 |
CCS | 33 | 17 | 51.5 | 5 | 15.2 | 3 | 9.1 | 4 | 12.1 | 0 | 0.0 | 3 | 9.1 | 0 | 0.0 | 1 | 0.03 |
CCSLGT | 5 | 4 | 80.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 20.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PPMS | 2 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 |
Myoepithelial neoplasm | 42 | 0 | 0.0 | 8 | 19.0 | 3 | 7.1 | 2 | 4.8 | 0 | 0.0 | 7 | 16.7 | 2 | 4.8 | 17 | 40.5 |
LGFMS and SEF | 19 | 0 | 0.0 | 1 | 5.3 | 1 | 5.3 | 3 | 15.8 | 6 | 31.6 | 1 | 5.3 | 1 | 5.3 | 6 | 31.6 |
Abbreviations: AFH=angiomatoid fibrous histiocytoma; CCS=clear cell sarcoma; CCSLGT=clear cell sarcoma-like tumour of the gastrointestinal tract; DSRCT=desmoplastic small round cell tumour; EMC=extraskeletal myxoid chondrosarcoma; LGFMS=low-grade fibromyxoid sarcoma; LPS=liposarcoma; NA=not applicable; ND=not done; PPMS=primary pulmonary myxoid sarcoma; RT–PCR=reverse transcription–PCR; SEF=sclerosing epithelioid fibrosarcoma.